Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β

BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive and associated with poor prognosis. Basic research to develop new treatment regimens is critically needed. METHODS: The effects of imatinib mesylate on MPNSTs were examined in six human MPNST cell lines and in a xeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohishi, Jun, Aoki, Mikiko, Nabeshima, Kazuki, Suzumiya, Junji, Takeuchi, Tamotsu, Ogose, Akira, Hakozaki, Michiyuki, Yamashita, Yuichi, Iwasaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654969/
https://www.ncbi.nlm.nih.gov/pubmed/23642185
http://dx.doi.org/10.1186/1471-2407-13-224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654969/
https://www.ncbi.nlm.nih.gov/pubmed/23642185
http://dx.doi.org/10.1186/1471-2407-13-224

Ejemplares similares